Health-related quality of life advantage of long-acting injectable antipsychotic treatment for schizophrenia: a time trade-off study (Q36015629)

11 August 2017

Health-related quality of life advantage of long-acting injectable antipsychotic treatment for schizophrenia: a time trade-off study (English)

1 reference

11 August 2017

0 references

1 reference

Richard H Osborne

1

0 references

author name string

Andrew Dalton

2

1 reference

11 August 2017

Judy Hertel

3

1 reference

11 August 2017

Rudolf Schrover

4

1 reference

11 August 2017

Dell Kingsford Smith

5

1 reference

11 August 2017

2 April 2012

1 reference

Health and Quality of Life Outcomes

11 August 2017

1 reference

11 August 2017

10

1 reference

11 August 2017

35

1 reference

Historical perspective on antipsychotic long-acting injections

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Valuation of transfusion-free living in MDS: results of health utility interviews with patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Utility measurement in healthcare: the things I never got to.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Quality of life related to fear of falling and hip fracture in older women: a time trade off study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Antipsychotic long-acting injections: prescribing practice in the UK.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Up to a quarter of the Australian population may have suboptimal health literacy depending upon the measurement tool: results from a population-based survey.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Quality of life related to oral versus subcutaneous iron chelation: a time trade-off study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369822

Methodology for measuring health-state preferences--II: Scaling methods

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22472127

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22472127

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1477-7525-10-35

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22472127

1 reference